The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Elevated Levels of Inflammatory Cytokines Predict Survival in Idiopathic and Familial Pulmonary Arterial Hypertension
Open accessAbstract
Background— Inflammation is a feature of pulmonary arterial hypertension (PAH), and increased circulating levels of cytokines are reported in patients with PAH. However, to date, no information exists on the significance of elevated cytokines or their potential as biomarkers. We sought to determine the levels of a range of cytokines in PAH and to examine their impact on survival and relationship to hemodynamic indexes. Methods and Results— We measured levels of serum cytokines (tumor necrosis factor-α, interferon-γ and interleukin-1β, -2, -4, -5, -6, -8, -10, -12p70, and -13) using ELISAs in idiopathic and heritable PAH patients (n=60). Concurrent clinical data included hemodynamics, 6-minute walk distance, and survival time from sampling to death or transplantation. Healthy volunteers served as control subjects (n=21). PAH patients had significantly higher levels of interleukin-1β, -2, -4, -6, -8, -10, and -12p70 and tumor necrosis factor-α compared with healthy control subjects. Kaplan-Meier analysis showed that levels of interleukin-6, 8, 10, and 12p70 predicted survival in patients. For example, 5-year survival with interleukin-6 levels of >9 pg/mL was 30% compared with 63% for patients with levels ≤9 pg/mL ( P =0.008). In this PAH cohort, cytokine levels were superior to traditional markers of prognosis such as 6-minute walk distance and hemodynamics. Conclusions— This study illustrates dysregulation of a broad range of inflammatory mediators in idiopathic and familial PAH and demonstrates that cytokine levels have a previously unrecognized impact on patient survival. They may prove to be useful biomarkers and provide insight into the contribution of inflammation in PAH.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Clinical classification of pulmonary hypertension
Simonneau, G., Galiè, N., Rubin, L. J., Langleben, D., Seeger, W., Domenighetti, G., Gibbs, S., Lebrec, D., Speich, R., Beghetti, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.02.037 · Cited by 1,897
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Lane, K. B., Machado, R. D., Pauciulo, M. W., Thomson, J. R., Phillips, J. A., Loyd, J. E., Nichols, W. C., & Trembath, R. C. (2000) · Nature Genetics · doi:10.1038/79226 · Cited by 1,495
Self-citationPencina, M. J., & D'Agostino, R. B. (2004) · Statistics in Medicine · doi:10.1002/sim.1802 · Cited by 1,444
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M., Nunes, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. É. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,383
Li, A., Dubey, S., Varney, M. L., Dave, B. J., & Singh, R. K. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3369 · Cited by 1,332
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Deng, Z., Morse, J. H., Slager, S. L., Cuervo, N., Moore, K. J., Venetos, G., Kalachikov, S., Cayanis, E., Fischer, S. G., Barst, R. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/303059 · Cited by 1,206
MIYAMOTO, S., NAGAYA, N., SATOH, T., KYOTANI, S., SAKAMAKI, F., FUJITA, M., NAKANISHI, N., & MIYATAKE, K. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9906015 · Cited by 1,154
Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G., & Emilie, D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.5.7735624 · Cited by 797
Interleukin-6 Overexpression Induces Pulmonary Hypertension
Steiner, M. K., Syrkina, O. L., Kolliputi, N., Mark, E. J., Hales, C. A., & Waxman, A. B. (2009) · Circulation Research · doi:10.1161/circresaha.108.182014 · Cited by 655
Brock, M., Trenkmann, M., Gay, R. E., Michel, B. A., Gay, S., Fischler, M., Ulrich, S., Speich, R., & Huber, L. C. (2009) · Circulation Research · doi:10.1161/circresaha.109.197491 · Cited by 465
Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice
Savale, L., Tu, L., Rideau, D., Izziki, M., Maitre, B., Adnot, S., & Eddahibi, S. (2009) · Respiratory Research · doi:10.1186/1465-9921-10-6 · Cited by 313
Li, A., Varney, M. L., Valasek, J., Godfrey, M., Dave, B. J., & Singh, R. K. (2005) · Angiogenesis · doi:10.1007/s10456-005-5208-4 · Cited by 285
Interleukin-8. A mitogen and chemoattractant for vascular smooth muscle cells.
Yue, T. L., Wang, X., Sung, C. P., Olson, B., McKenna, P. J., Gu, J. L., & Feuerstein, G. Z. (1994) · Circulation Research · doi:10.1161/01.res.75.1.1 · Cited by 260
Transforming Growth Factor-β Receptor Mutations and Pulmonary Arterial Hypertension in Childhood
Harrison, R. E., Berger, R., Haworth, S. G., Tulloh, R., Mache, C. J., Morrell, N. W., Aldred, M. A., & Trembath, R. C. (2005) · Circulation · doi:10.1161/01.cir.0000153798.78540.87 · Cited by 241
Self-citationTumor Necrosis Factor-α and Mortality in Heart Failure: A Community Study
Dunlay, S. M., Weston, S. A., Redfield, M. M., Killian, J. M., & Roger, V. L. (2008) · Circulation · doi:10.1161/circulationaha.107.759191 · Cited by 186
Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle
Hagen, M. E., Fagan, K., Steudel, W., et al. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00197.2006 · Cited by 158
Itoh, T., Nagaya, N., Ishibashi‐Ueda, H., Kyotani, S., Oya, H., Sakamaki, F., Kimura, H., & Nakanishi, N. (2006) · Respirology · doi:10.1111/j.1440-1843.2006.00821.x · Cited by 149
Pulmonary hypertension and inflammation
Tuder, R. M., & Voelkel, N. F. (1998) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(98)90020-8 · Cited by 128
Ito, T., Okada, T., Miyashita, H., Nomoto, T., Nonaka‐Sarukawa, M., Uchibori, R., Maeda, Y., Urabe, M., Mizukami, H., Kume, A., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.153023 · Cited by 112
Nabata, T., Morimoto, S., Koh, E., Shiraishi, T., & Ogihara, T. (1990) · PubMed · Cited by 81
Yoshioka, T., Okada, T., Maeda, Y., Ikeda, U., Shimpo, M., Nomoto, T., Takeuchi, K., Nonaka‐Sarukawa, M., Ito, T., Takahashi, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302348 · Cited by 79
Monocrotaline induces interleukin-6 mRNA expression in rat lungs.
Bhargava, A., Kumar, A., Yuan, N., Mh, G., & Mathew, R. (1999) · PubMed · Cited by 70
Pulmonary Hypertension in Rats 2.
Miyata, M., Sakuma, F., Yoshimura, A., et al. (2009) · International Archives of Allergy and Immunology · doi:10.1159/000237166 · Cited by 69
Interleukin-8 is chemotactic for vascular smooth muscle cells
Yue, T.-L., McKenna, P., Gu, J.-L., & Feuerstein, G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90549-w · Cited by 55
IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes.
Ferro, T. J., Johnson, A., Everitt, J. I., & Malik, A. B. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.6.1916 · Cited by 41
Cited by
Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension
Rabinovitch, M., Guignabert, C., Humbert, M., & Nicolls, M. R. (2014) · Circulation Research · doi:10.1161/circresaha.113.301141 · Cited by 1,029
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan, T., Ormiston, M. L., Ryan, J. J., & Archer, S. L. (2018) · BMJ · doi:10.1136/bmj.j5492 · Cited by 998
Pulmonary Arterial Hypertension
Hassoun, P. M. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2000348 · Cited by 693
Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension
Tuder, R. M., Archer, S. L., Dorfmüller, P., Erzurum, S. C., Guignabert, C., Michelakis, E., Rabinovitch, M., Schermuly, R., Stenmark, K. R., & Morrell, N. W. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.025 · Cited by 585
Self-citationPathology of Pulmonary Hypertension
Tuder, R. M., Stacher, E., Robinson, J., Kumar, R., & Graham, B. B. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.08.009 · Cited by 439
Metadata
- Authors
- Soon, E., Holmes, A. M., Treacy, C. M., Doughty, N. J., Southgate, L., Machado, R. D., Trembath, R. C., Jennings, S., Barker, L., Nicklin, P., Walker, C., Budd, D. C., Pepke-Zaba, J., & Morrell, N. W.
- Venue
- Circulation
- Published
- 2010-08-31
- Volume
- 122
- Issue
- 9
- Pages
- 920-927
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2157601642
- Cited by
- 802
- References
- 28
- FWCI
- 27.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.